Press Lassa-Fighting Legacy: Forgotten man, forgotten disease Ars Technica recently published an in-depth article on the history of Lassa fever in Sierra…adminJanuary 25, 2019
Workshop CViSB Systems Biology Workshop We are pleased to announce that our sister consortium CViSB, is hosting the first annual…Kristian AndersenDecember 11, 2018
Publication Genomic sequencing study of Lassa virus in Nigeria during 2018 published in NEJM As a result of years of collaborative investment in training Nigerian scientists, genomic information about…Kristian AndersenOctober 21, 2018
Publication How do antibodies protect against infection with Ebola virus? In two papers published in Cell and Cell Host Microbe VHFC investigators describe in detail antibody…Kristian AndersenAugust 9, 2018
Publication T cell responses in patients during the Ebola epidemic VHFC Scientists conducting the first comprehensive study of key immune system cells - collected from…Kristian AndersenJuly 30, 2018
Publication Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever A new study from VHFC researchers in the journal Scientific Reports provide validation for a…Kristian AndersenApril 12, 2018
Press release Zalgen Labs awarded NIH grant to advance diagnostic products VHFC partner, Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected…Kristian AndersenMarch 26, 2018
Publication VHFC researchers describe predictors of Lassa fever outcome A team of scientists at led by Pardis Sabeti at the Broad Institute has published…Kristian AndersenMarch 12, 2018
Press release Partner center CViSB launched with a $15 million grant from NIAID With a new $15 million grant, VHFC scientists at Scripps Research are gearing up for…Kristian AndersenFebruary 27, 2018
Press release Tulane University awarded $12 million to create Lassa vaccine and treatment The National Institutes of Health has awarded Tulane University more than $12 million to test…adminJuly 12, 2017